Filing Flows › Bausch Health Companies (BHC) › Q3 2026 › vs Q2 2026
Bausch Health Companies (BHC) Q3 2026 vs Q2 2026 (quarter over quarter)
Bausch Health Companies's revenue rose $89.0M (+3%) from $2.9B in Q2 2026 to $2.9B in Q3 2026. The biggest changes: Product sales +$87.0M (+3%); Other revenues +$2.0M (+7%). Operating margin 33.4% against 25.9% (+7.5 pts).
Bausch Health Companies, Q3 2026: revenue $2.9B (+10% year over year), operating margin 33.4%, net earnings $436M, operating cash flow $814M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Operating margin | 33.4% | 25.9% | +7.5 pts |
| Net margin | 14.8% | 9.0% | +5.8 pts |
| Free cash flow margin | 25.4% | 20.8% | +4.6 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Product sales | $2.9B | $2.8B | $87.0M | +3% |
| Other revenues | $29.0M | $27.0M | $2.0M | +7% |
| Revenue | $2.9B | $2.9B | $89.0M | +3% |
| Operating profit | $983M | $740M | $243M | +33% |
| Costs & expenses | $2.0B | $2.1B | −$154M | -7% |
| Pre-tax earnings | $597M | $348M | $249M | +72% |
| Other expense, net | $386M | $392M | −$6.0M | -2% |
| Research & development | $141M | $173M | −$32.0M | -18% |
| SG&A | $834M | $907M | −$73.0M | -8% |
| Other operating costs | $983M | $1.0B | −$49.0M | -5% |
| Net earnings | $436M | $258M | $178M | +69% |
| Minority interests | $10.0M | $2.0M | $8.0M | +400% |
| Income tax | $151M | $88.0M | $63.0M | +72% |
| Depreciation & amortization | $284M | $281M | $3.0M | +1% |
| Share-based compensation | $52.0M | $54.0M | −$2.0M | -4% |
| Working capital & other | $42.0M | $77.0M | −$35.0M | -45% |
| Operating cash flow | $814M | $670M | $144M | +21% |
| Free cash flow (OCF − capex) | $748M | $593M | $155M | +26% |
| Capital expenditures | $66.0M | $77.0M | −$11.0M | -14% |
Questions
How much did Bausch Health Companies's revenue grow quarter over quarter in Q3 2026?
Bausch Health Companies's revenue rose $89.0M (+3%) from $2.9B in Q2 2026 to $2.9B in Q3 2026.
What drove Bausch Health Companies's revenue change in Q3 2026?
Product sales +$87.0M (+3%); Other revenues +$2.0M (+7%).